RFK Jr. and Andrew Wakefield Lead Sold-Out Anti-Vaccine Conference
Anti-Vaccine Conference Attracts Notable Figures
The upcoming conference hosted by the Children’s Health Defense (CHD) is set for September 17 and is framed as a step towards a “more perfect future” in health freedom advocacy. Attendees will have the opportunity to engage in discussions focusing on the contemporary challenges and prospects facing the health freedom movement. An opening reception will take place the night before.
Among the notable speakers is Senator Ron Johnson from Wisconsin, known for his outspoken opposition to vaccines. Other prominent figures scheduled to speak include Senator Rand Paul from Kentucky, Mark Gorton, the president of the Kennedy-aligned MAHA Institute, and Jan Jekielek, a senior editor at the right-leaning Epoch Times. Additionally, several CHD executives, including CEO Mary Holland, will also be present.
While in-person tickets priced at $250 have already sold out, limited seating passes in a designated area of the main conference room are still available for $125. For those unable to attend in person, livestream access can be purchased for $100.
Robert F. Kennedy Jr., who officially distanced himself from CHD when he took on the role of Health Secretary in early 2025, has recently made efforts to separate from his previous anti-vaccine stance. He has repeatedly stated in confirmation hearings that he is “pro-vaccine,” despite a long history of being associated with anti-vaccine activism.
Kennedy’s participation in a blatantly anti-vaccine event marks a notable turn as he seems to be embracing his ideological roots. This comes in the wake of reports indicating that President Trump has encouraged Kennedy to fervently pursue the debunked narrative linking vaccines to autism.
Editor’s Take
This development is significant as it underscores the ongoing tension within public health discussions, particularly regarding vaccine safety. The gathering of high-profile political figures at an anti-vaccine event may influence public perception and policy, shaping future dialogue around health freedoms. For the technology and healthcare sectors, this could mean continued challenges in public trust and progress towards better health outcomes.
Source: arstechnica.com